The Latest Dose
Ep. 3: Considering the Patient & Improving the Clinical Research Ecosystem

Ep. 3: Considering the Patient & Improving the Clinical Research Ecosystem

February 6, 2020

Kathy Vandebelt speaks with Joe Kim, Eli Lilly & Company’s Sr. Advisor, Digital Health Office, and host of Lilly’s podcast Elixir Factor, which explores the factors that inspire bold advances in science. He aims to improve the capabilities for one of humankind's biggest social issues - the development of new medicine. Hear Joe’s opinions on approaches, initiatives, & technology to make clinical research more patient-friendly.

Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

February 6, 2020

In this episode, Host Kathy Vandebelt discusses decentralized trials with Dylan Rosser, Executive Director of Global Development Operations at Amgen. Dylan brings to light the various virtual components that are used and can be stitched together in a trial. He also talks about the importance of the patient in clinical research, and highlights the benefits decentralized trials can bring to them.

Ep. 1: Improving Clinical Research: Go it Alone, or Join Industry-Driven Initiatives?

Ep. 1: Improving Clinical Research: Go it Alone, or Join Industry-Driven Initiatives?

February 4, 2020

In this episode, Oracle Health Sciences Global Head of Innovation, Kathy Vandebelt, speak with Allergan's Director of Global Study Start Up and Essential Documents, Lorena Gomez, about TransCelerate and her role since the beginning. Tune in to hear her opinions about industry initiatives, insights into the Shared Investigator Platform program, and what she thinks they should work on next.

Podbean App

Play this podcast on Podbean App